Ausperbio Therapeutics Inc.
Clinical trials sponsored by Ausperbio Therapeutics Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot aims to tame hepatitis b without daily pills Results expected May 2027 (estimated)
-
New shot aims to tame hepatitis b without daily pills
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called AHB-137 in 70 adults with chronic hepatitis B who are already on antiviral pills. The drug is given as a shot under the skin. The goal is to see if it can lower the virus to undetectable levels and allow some people to stop the…
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New shot aims to cure hepatitis b – early trial underway
Disease control Recruiting nowThis Phase 2 trial tests an experimental drug called AHB-137 in 84 adults with chronic hepatitis B who are already on antiviral therapy. The goal is to see if AHB-137 can clear the hepatitis B surface antigen and keep the virus under control, potentially leading to a functional c…
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC